Timothy Warbington Discloses 13.7% Stake in Creative Medical Technology
Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc., disclosed a 13.7% stake in the company’s common stock via a Schedule 13D filing.
Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc., disclosed a 13.7% stake in the company’s common stock via a Schedule 13D filing.